253 related articles for article (PubMed ID: 11504539)
1. Altered biology of adeno-associated virus type 2 and human papillomavirus during dual infection of natural host tissue.
Meyers C; Alam S; Mane M; Hermonat PL
Virology; 2001 Aug; 287(1):30-9. PubMed ID: 11504539
[TBL] [Abstract][Full Text] [Related]
2. Multiple human papillomavirus genes affect the adeno-associated virus life cycle.
You H; Liu Y; Prasad CK; Agrawal N; Zhang D; Bandyopadhyay S; Liu H; Kay HH; Mehta JL; Hermonat PL
Virology; 2006 Jan; 344(2):532-40. PubMed ID: 16203022
[TBL] [Abstract][Full Text] [Related]
3. Analysis of adeno-associated virus and HPV interaction.
Hermonat PL; You H; Chiriva-Internati CM; Liu Y
Methods Mol Med; 2005; 119():397-409. PubMed ID: 16350413
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-ras chimeric.
Hermonat PL; Plott RT; Santin AD; Parham GP; Flick JT
Gynecol Oncol; 1997 Sep; 66(3):487-94. PubMed ID: 9299265
[TBL] [Abstract][Full Text] [Related]
5. Temporal acceleration of the human papillomavirus life cycle by adeno-associated virus (AAV) type 2 superinfection in natural host tissue.
Agrawal N; Mane M; Chiriva-Internati M; Roman JJ; Hermonat PL
Virology; 2002 Jun; 297(2):203-10. PubMed ID: 12083819
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer.
Hermonat PL
Cancer Res; 1994 Apr; 54(8):2278-81. PubMed ID: 8174138
[TBL] [Abstract][Full Text] [Related]
7. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
Hermonat PL; Santin AD; Zhan D
J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
[TBL] [Abstract][Full Text] [Related]
8. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
9. Adenoassociated virus type 2-induced inhibition of the human papillomavirus type 18 promoter in transgenic mice.
Walz CM; Correa-Ochoa MM; Müller M; Schlehofer JR
Virology; 2002 Feb; 293(1):172-81. PubMed ID: 11853410
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the coexistence of two genital HPV types within the same host cell in vitro.
McLaughlin-Drubin ME; Meyers C
Virology; 2004 Apr; 321(2):173-80. PubMed ID: 15051378
[TBL] [Abstract][Full Text] [Related]
11. Inhibition/stimulation of bovine papillomavirus by adeno-associated virus is time as well as multiplicity dependent.
Hermonat PL; Meyers C; Parham GP; Santin AD
Virology; 1998 Aug; 247(2):240-50. PubMed ID: 9705917
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumorigenicity in cervical carcinoma HeLa cells by an episomal form of adeno-associated virus.
Wu FY; Wu CY; Lin CH; Wu CH
Int J Oncol; 1999 Jul; 15(1):101-6. PubMed ID: 10375600
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model.
Meyers C; Mane M; Kokorina N; Alam S; Hermonat PL
Virology; 2000 Jul; 272(2):338-46. PubMed ID: 10873777
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus DNA is present in a subset of unselected breast cancers.
Liu Y; Klimberg VS; Andrews NR; Hicks CR; Peng H; Chiriva-Internati M; Henry-Tillman R; Hermonat PL
J Hum Virol; 2001; 4(6):329-34. PubMed ID: 12082399
[TBL] [Abstract][Full Text] [Related]
15. Detection of adeno-associated virus type 2 genome in cervical carcinoma.
Zheng BY; Li XD; Wiklund F; Chowdhry S; Angstrom T; Hallmans G; Dillner J; Wallin KL
Br J Cancer; 2006 Jun; 94(12):1913-7. PubMed ID: 16736006
[TBL] [Abstract][Full Text] [Related]
16. Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium.
Walz C; Deprez A; Dupressoir T; Dürst M; Rabreau M; Schlehofer JR
J Gen Virol; 1997 Jun; 78 ( Pt 6)():1441-52. PubMed ID: 9191942
[TBL] [Abstract][Full Text] [Related]
17. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus from archival tissues in cervical cancer patients in Mauritius.
Rughooputh S; Eddoo R; Manraj S; Jeebun N; Greenwell P
J Clin Virol; 2006 Feb; 35(2):173-8. PubMed ID: 16115796
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients.
Liu VW; Tsang P; Yip A; Ng TY; Wong LC; Ngan HY
Gynecol Oncol; 2001 Aug; 82(2):269-72. PubMed ID: 11531278
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between human papillomavirus DNA in the lymph nodes and metastasis of early-stage cervical carcinoma].
Sun Y; Liu GB; Yu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):796-8. PubMed ID: 18504207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
